OIG on medical supplier fraud
This article was originally published in The Gray Sheet
Executive Summary
An HHS Office of Inspector General 1report released March 3 finds persisting problems in Medicare compliance among suppliers of durable medical equipment, prosthetics, orthotics and supplies (DMEPOS), including hospital beds, wheelchairs and artificial limbs. OIG inspected 905 suppliers in Los Angeles County, one of the "hotspots" of supplier problems, and found in addition to other violations that 13% of suppliers did not have a physical facility or were closed during repeated visits. OIG recommends that CMS conduct more unannounced site visits, increase prepayment reviews of DMEPOS claims, and establish minimum inventory requirements for product types. CMS says it has already addressed a number of the identified fraud vulnerabilities (2"The Gray Sheet" July 9, 2007, p. 14)
You may also be interested in...
CMS Targets Fraud Among DME Suppliers In Florida, Los Angeles
All durable medical equipment suppliers in three counties in South Florida and four in the Los Angeles area will have to reapply for CMS-855S numbers that allow them to bill Medicare for beneficiaries' DME, prosthetics, orthotics and other medical supplies. The effort is part of a demonstration project launched by CMS July 2
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.